Xolair
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Omalizumab (Xolair®), a humanized anti-IgE monoclonal antibody, is effective and well-tolerated in patients with chronic…
Solar urticaria (SU) is characterised by intense pruritus or burning, erythemal flare and whealing, usually beginning within 5-10…
BackgroundThe Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT) is a trial to determine the clinical efficacy and safety of…
Omalizumab (Xolair®) is a recombinant humanized monoclonal antibody that selectively binds to human immunoglobulin E (IgE…
Omalizumab (Xolair®) is a humanized monoclonal antibody used in the treatment of adolescent and adult patients with moderate to…
Xolair is a monoclonal antibody that binds the Ce3 domain of IgEs, inducing a conforma-tional change of the immunoglobulin, a…
Background: Two atopic patients suffering from severe allergy difficult to handle by conventional medication were given Xolair…
Anamnese: Diagnostik: Verlauf: History: Diagnostics: Medical Course:
ANTIBODY-BASED PRODUCTS Bexxar CEA-Scan Herceptin HumaSPECT Humira Indimacis 125 LeukoScan MabCampath / Campath-1H MabThera…
UNLABELLED
Omalizumab [anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, olizumab…